Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Meijssen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 1, 2003
Intra-individual variations of fasting plasma lipids, apolipoproteins and postprandial lipemia in familial combined hyperlipidemia compared to controlsD Delawi, S Meijssen, M Castro Cabezas
The Journal of Clinical Endocrinology and Metabolism|October 9, 2004
Effects of atorvastatin on fasting plasma and marginated apolipoproteins B48 and B100 in large, triglyceride-rich lipoproteins in familial combined hyperlipidemiaC Verseyden, S Meijssen, M Castro Cabezas
Journal of Lipid Research|February 28, 2002
Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemiaC Verseyden, S Meijssen, M Castro Cabezas
Biochemical and Biophysical Research Communications|August 26, 1998
Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor geneO Bakker, F Hudig, S Meijssen, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Effects of atorvastatin on the clearance of triglyceride-rich lipoproteins in familial combined hyperlipidemiaM Castro Cabezas, C Verseyden, S Meijssen, et al.
Journal of Lipid Research|August 19, 2003
Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemiaC Verseyden, S Meijssen, H van Dijk, et al.
Journal of Lipid Research|July 7, 2000
In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemiaS Meijssen, M C Cabezas, T B Twickler, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
In vivo modulation of plasma free fatty acids in patients with familial combined hyperlipidemia using lipid-lowering medicationS Meijssen, R J Derksen, S Bilecen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2002
Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemiaS Meijssen, H van Dijk, C Verseyden, et al.
Atherosclerosis|February 27, 2001
Diurnal triglyceride profiles: a novel approach to study triglyceride changesM Castro Cabezas, C J Halkes, S Meijssen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 1, 2003
Intra-individual variations of fasting plasma lipids, apolipoproteins and postprandial lipemia in familial combined hyperlipidemia compared to controlsD Delawi, S Meijssen, M Castro Cabezas
The Journal of Clinical Endocrinology and Metabolism|October 9, 2004
Effects of atorvastatin on fasting plasma and marginated apolipoproteins B48 and B100 in large, triglyceride-rich lipoproteins in familial combined hyperlipidemiaC Verseyden, S Meijssen, M Castro Cabezas
Journal of Lipid Research|February 28, 2002
Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemiaC Verseyden, S Meijssen, M Castro Cabezas
Biochemical and Biophysical Research Communications|August 26, 1998
Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor geneO Bakker, F Hudig, S Meijssen, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Effects of atorvastatin on the clearance of triglyceride-rich lipoproteins in familial combined hyperlipidemiaM Castro Cabezas, C Verseyden, S Meijssen, et al.
Journal of Lipid Research|August 19, 2003
Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemiaC Verseyden, S Meijssen, H van Dijk, et al.
Journal of Lipid Research|July 7, 2000
In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemiaS Meijssen, M C Cabezas, T B Twickler, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
In vivo modulation of plasma free fatty acids in patients with familial combined hyperlipidemia using lipid-lowering medicationS Meijssen, R J Derksen, S Bilecen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2002
Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemiaS Meijssen, H van Dijk, C Verseyden, et al.
Atherosclerosis|February 27, 2001
Diurnal triglyceride profiles: a novel approach to study triglyceride changesM Castro Cabezas, C J Halkes, S Meijssen, et al.
Pageof 2